Clinical Trial

Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients

Study acronym: PEPITS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 23, 2024 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Schizophrenia affects about 0.7% of the population. Poor insight, which is common in this disease, linked to poor drug compliance is leads to rehospitalisation with major impact on quality of life. Indeed, many patients relapse with exacerbation of symptoms. Psychoeducation can improve therapeutic alliance and medication compliance. In this context, an individual psycho-education program (PEPITS) has been developed. PEPITS carried out by nurses during the initial stages of hospitalisation. The hypothesis is that PEPITS program will decrease relapse and improve the compliance and insight and and so the quality of life.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-04-08; most recent amendment 2024-04-22.
Status change: Not Yet Recruiting → Recruiting 2022-11-04
Trial Details
NCT Number NCT05329363
Lead Sponsor University Hospital, Tours
Conditions Schizophrenia
Enrollment 200 participants
Start Date 2022-06-17
Primary Completion 2026-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2024-04-23